Zhang, Xian http://orcid.org/0000-0001-9674-7886
Li, Shun
Malik, Isha
Do, Mytrang H.
Ji, Liangliang http://orcid.org/0000-0001-8572-315X
Chou, Chun http://orcid.org/0000-0001-7147-4236
Shi, Wei
Capistrano, Kristelle J.
Zhang, Jing
Hsu, Ting-Wei
Nixon, Briana G.
Xu, Ke
Wang, Xinxin
Ballabio, Andrea http://orcid.org/0000-0003-1381-4604
Schmidt, Laura S.
Linehan, W. Marston http://orcid.org/0000-0001-7983-3109
Li, Ming O. http://orcid.org/0000-0002-1383-0535
Article History
Received: 20 November 2022
Accepted: 24 May 2023
First Online: 28 June 2023
Competing interests
: MSKCC has filed a patent application (number 63/502054) with the US Patent and Trademark Office directed towards targeting the nutrient-sensing pathway in macrophages for cancer immunotherapy. M.O.L. is a scientific advisory board member of and holds equity or stock options in Amberstone Biosciences and META Pharmaceuticals. A.B. is cofounder of Casma Therapeutics and advisory board member of Next Generation Diagnostics, Avilar Therapeutics and Coave Therapeutics. The other authors declare no competing interests.